医学
克罗恩病
疾病
生物制剂
英夫利昔单抗
入射(几何)
重症监护医学
免疫学
内科学
物理
光学
作者
Stacey Rolak,Sunanda V. Kane
标识
DOI:10.1016/j.gtc.2021.12.004
摘要
Crohn's disease is a chronic and progressive immune-mediated disease with increasing incidence worldwide. There are no curative therapies. The primary agents used in the treatment of Crohn's disease are aminosalicylates, corticosteroids, immunomodulators, and biologics. Each agent has different roles in the induction and maintenance of remission of disease. The biologics available include anti-TNF agents, anti-integrins, and anti-interleukins. The choice of initial biologic therapy should be determined through shared decision-making between the patient and provider.
科研通智能强力驱动
Strongly Powered by AbleSci AI